| 3.60 Delayed Data As of 4:00pm ET |  +0.20 / +5.88%Today’s Change | 3.32 Today|||52-Week Range 6.67 | -13.04% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Cooper Laurence James Neil Chief Executive Officer |  Sale | 5/05/2018 | 123,333 | $4.41 | $543.9K | -26.41% |
Belbel Caesar J | Sale | 12/30/2017 | 31,450 | $4.14 | $130.2K | -23.42% |
Lebel Francois /ziopharm/ Executive Vice President-Research & Development | Sale | 12/30/2017 | 31,450 | $4.14 | $130.2K | -23.42% |
Cooper Laurence James Neil Chief Executive Officer | Sale | 12/30/2017 | 26,178 | $4.14 | $108.4K | -23.42% |
Belbel Caesar J | Sale | 12/31/2017 | 21,667 | $4.14 | $89.7K | -23.42% |
Lebel Francois /ziopharm/ Executive Vice President-Research & Development | Sale | 12/31/2017 | 21,667 | $4.14 | $89.7K | -23.42% |
Cooper Laurence James Neil Chief Executive Officer | Sale | 12/31/2017 | 16,157 | $4.14 | $66.9K | -23.42% |
Fowler Wyche Jr Director | Sale | 12/11/2017 | 15,800 | $4.20 | $66.4K | -19.05% |
Cannon James Anthony Director | Sale | 12/12/2017 | 13,094 | $4.17 | $54.6K | -18.47% |
Brennan Murray F Director | Sale | 11/20/2017 | 12,639 | $4.32 | $54.6K | -21.30% |
